ZIMMER BIOMET HOLDINGS, INC.

Zimmer Biomet is a global medical technology company that designs, manufactures, and markets a comprehensive portfolio of products aimed at maximizing mobility and improving health. The company's offerings include orthopedic reconstructive products; sports medicine, biologics, extremities, and trauma products; craniomaxillofacial and thoracic (CMFT) products; bone cement; surgical products; and integrated digital and robotic technologies that utilize data, data analytics, and artificial intelligence. These products and solutions are used to treat patients with disorders or injuries to bones, joints, or supporting soft tissues. Zimmer Biomet Holdings, Inc. was incorporated in Delaware in 2001, with its history tracing back to Zimmer Manufacturing Company, founded in Warsaw, Indiana, in 1927. The company became an independent public entity on August 6, 2001, after being spun off from its former parent. In 2015, Zimmer Biomet acquired LVB Acquisition, Inc., the parent company of Biomet, Inc., which then became wholly-owned subsidiaries. Concurrently, the company changed its name from Zimmer Holdings, Inc. to Zimmer Biomet Holdings, Inc. Primary customers include orthopedic surgeons, neurosurgeons, other specialists, healthcare institutions, stocking distributors, healthcare dealers, and healthcare purchasing organizations or buying groups. Products are marketed and sold through two main channels: directly to healthcare institutions like hospitals and ambulatory surgery centers, and through stocking distributors and healthcare dealers.